Cargando…
Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences
Maintenance of telomere length is the most consistent attribute of cancer cells. Tightly connected to their capacity to overcome replicative mortality, it is achieved either by activation of telomerase or an Alternative mechanism of Lengthening of Telomeres (ALT). Disruption of either of these mecha...
Autores principales: | Yu, Yue, Katiyar, Shashank P, Sundar, Durai, Kaul, Zeenia, Miyako, Eijiro, Zhang, Zhenya, Kaul, Sunil C, Reddel, Roger R, Wadhwa, Renu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477593/ https://www.ncbi.nlm.nih.gov/pubmed/28425984 http://dx.doi.org/10.1038/cddis.2017.33 |
Ejemplares similares
-
2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental Evidences
por: Chaudhary, Anupama, et al.
Publicado: (2019) -
Molecular dynamics simulations and experimental studies reveal differential permeability of withaferin-A and withanone across the model cell membrane
por: Wadhwa, Renu, et al.
Publicado: (2021) -
Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone
por: Malik, Vidhi, et al.
Publicado: (2022) -
Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl ester as ATP-competitive inhibitors of BRAF: A bioinformatics study
por: Malik, Vidhi, et al.
Publicado: (2021) -
Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers
por: Malik, Vidhi, et al.
Publicado: (2021)